340B Drug Pricing Program
This funding record is inactive. Please see the program website or contact the program
sponsor to
determine if this program is currently accepting applications or will open again in the future.
Areas with a declared Public Health Emergency (PHE) may immediately enroll in the 340B Program during the PHE Declaration rather than having to wait for the normal quarterly registration period.
The 340B Drug Pricing Program is a federal program that requires drug manufacturers to provide outpatient drugs to eligible healthcare centers, clinics, and hospitals at a reduced price. The program offers a way for eligible safety-net organizations to ensure access to medications.
Comprehensive pharmacy services include patient access to affordable pharmaceuticals, application of "best practices" and efficient pharmacy management and the application of systems that improve patient outcomes through safe and effective medication use. Participation in the Program results in significant savings estimated to be 20% to 50% on the cost of pharmaceuticals for safety-net providers.
All of the following types of entities are eligible to participate in the program by the virtue of their status:
- Federally Qualified Health Centers and their look-alikes (FQHCs)
- Native Hawaiian Health Centers
- Tribal/Urban Indian Health Centers
- Ryan White HIV/AIDS Program Grantees
- Black lung clinics
- Comprehensive hemophilia diagnostic treatment centers
- Title X Family Planning Clinics
- Sexually Transmitted Disease Clinics
- Tuberculosis Clinics
- Disproportionate share hospitals
- Children's hospitals
- Critical Access Hospitals
- Free-standing cancer hospitals
- Rural referral centers
- Sole community hospitals
The program provides prescription drugs at a reduced cost to eligible entities. Participation in the program results in significant savings estimated to be 20% to 50% on the cost of pharmaceuticals for safety-net providers.
A link to the online registration process is available on the program website. Registration must be recertified each year.
Registration periods are open 4 times throughout the year, and are processed in quarterly cycles.
Funding cycles are as follows:
- January 1 - January 15 for an April 1 start date
- April 1 - April 15 for a July 1 start date
- July 1 - July 15 for an October 1 start date
- October 1 - October 15 for a January 1 start date
Related Content
Organizations (3)
- U.S. Department of Health and Human Services, view details
- Health Resources and Services Administration, view details
- Office of Pharmacy Affairs, view details
For complete information about funding programs, including your
application status, please contact funders directly. Summaries are provided
for your convenience only. RHIhub does not take part in application processes
or monitor application status.